GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunny Pharmtech Inc (ROCO:6676) » Definitions » Gross Margin %

Sunny Pharmtech (ROCO:6676) Gross Margin % : 59.90% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sunny Pharmtech Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Sunny Pharmtech's Gross Profit for the six months ended in Dec. 2024 was NT$110.5 Mil. Sunny Pharmtech's Revenue for the six months ended in Dec. 2024 was NT$184.5 Mil. Therefore, Sunny Pharmtech's Gross Margin % for the quarter that ended in Dec. 2024 was 59.90%.


The historical rank and industry rank for Sunny Pharmtech's Gross Margin % or its related term are showing as below:

ROCO:6676' s Gross Margin % Range Over the Past 10 Years
Min: 40.62   Med: 54.16   Max: 87.63
Current: 54.16


During the past 7 years, the highest Gross Margin % of Sunny Pharmtech was 87.63%. The lowest was 40.62%. And the median was 54.16%.

ROCO:6676's Gross Margin % is ranked worse than
57.01% of 742 companies
in the Biotechnology industry
Industry Median: 59.805 vs ROCO:6676: 54.16

Sunny Pharmtech had a gross margin of 59.90% for the quarter that ended in Dec. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Sunny Pharmtech was 6.70% per year.


Sunny Pharmtech Gross Margin % Historical Data

The historical data trend for Sunny Pharmtech's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunny Pharmtech Gross Margin % Chart

Sunny Pharmtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Margin %
Get a 7-Day Free Trial 53.36 48.03 57.48 66.58 54.16

Sunny Pharmtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.14 67.79 65.73 49.63 59.90

Competitive Comparison of Sunny Pharmtech's Gross Margin %

For the Biotechnology subindustry, Sunny Pharmtech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunny Pharmtech's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunny Pharmtech's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Sunny Pharmtech's Gross Margin % falls into.


;
;

Sunny Pharmtech Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Sunny Pharmtech's Gross Margin for the fiscal year that ended in Dec. 2024 is calculated as

Gross Margin % (A: Dec. 2024 )=Gross Profit (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=226.4 / 418.009
=(Revenue - Cost of Goods Sold) / Revenue
=(418.009 - 191.606) / 418.009
=54.16 %

Sunny Pharmtech's Gross Margin for the quarter that ended in Dec. 2024 is calculated as


Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=110.5 / 184.453
=(Revenue - Cost of Goods Sold) / Revenue
=(184.453 - 73.964) / 184.453
=59.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Sunny Pharmtech  (ROCO:6676) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Sunny Pharmtech had a gross margin of 59.90% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Sunny Pharmtech Gross Margin % Related Terms

Thank you for viewing the detailed overview of Sunny Pharmtech's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunny Pharmtech Business Description

Traded in Other Exchanges
N/A
Address
No.255,Longyuan 1st Road, Hsinchu Science Park, Longtan District, Taoyuan, TWN, 325002
Sunny Pharmtech Inc is a specialty pharmaceutical company. It is now fully-integrated, doing research, development, and manufacturing on both API and finished-dose products, which includes orals, liquids, semi-solids, and parenterals.

Sunny Pharmtech Headlines

No Headlines